110 related articles for article (PubMed ID: 33774030)
1. Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes.
Tsai YC; Huang CY; Hsueh YM; Fan YC; Fong YC; Huang SP; Geng JH; Chen LC; Lu TL; Bao BY
Life Sci; 2021 Jun; 275():119396. PubMed ID: 33774030
[TBL] [Abstract][Full Text] [Related]
2. Genetic Analysis Identifies the Role of
Huang CY; Huang SP; Hsueh YM; Chen LC; Lu TL; Bao BY
Cancer Genomics Proteomics; 2020; 17(6):827-833. PubMed ID: 33099483
[TBL] [Abstract][Full Text] [Related]
3. Identification of MAPK10 as a novel epigenetic marker for chromophobe kidney cancer.
Yoo KH; Park YK; Kim HS; Jung WW; Chang SG
Pathol Int; 2011 Jan; 61(1):52-4. PubMed ID: 21166945
[No Abstract] [Full Text] [Related]
4. Germline genetic variants in somatically significantly mutated genes in tumors are associated with renal cell carcinoma risk and outcome.
Shu X; Gu J; Huang M; Tannir NM; Matin SF; Karam JA; Wood CG; Wu X; Ye Y
Carcinogenesis; 2018 May; 39(6):752-757. PubMed ID: 29635281
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-4516-mediated regulation of
Wang Y; Jiang Q; Chakravarti A; Cai H; Xu Z; Wu W; Gu B; Li L; Cai W
J Med Genet; 2020 Sep; 57(9):634-642. PubMed ID: 32066630
[TBL] [Abstract][Full Text] [Related]
6. Hypoxia and renal cell carcinoma: The influence of HIF1A+1772C/T functional genetic polymorphism on prognosis.
Ferreira M; Teixeira A; Maurício J; Lobo F; Morais A; Medeiros R
Urol Oncol; 2017 Aug; 35(8):532.e25-532.e30. PubMed ID: 28476527
[TBL] [Abstract][Full Text] [Related]
7. Functional promoter -31G>C variant in survivin gene is associated with risk and progression of renal cell cancer in a Chinese population.
Qin C; Cao Q; Li P; Ju X; Wang M; Chen J; Wu Y; Meng X; Zhu J; Zhang Z; Lu Q; Yin C
PLoS One; 2012; 7(1):e28829. PubMed ID: 22295057
[TBL] [Abstract][Full Text] [Related]
8. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
Hirata H; Hinoda Y; Kikuno N; Kawamoto K; Suehiro Y; Tanaka Y; Dahiya R
Clin Cancer Res; 2007 Jul; 13(14):4123-9. PubMed ID: 17634539
[TBL] [Abstract][Full Text] [Related]
9. The polymorphisms in the VHL and HIF1A genes are associated with the prognosis but not the development of renal cell carcinoma.
Qin C; Cao Q; Ju X; Wang M; Meng X; Zhu J; Yan F; Li P; Ding Q; Chen J; Gu M; Zhang W; Yin C; Zhang Z
Ann Oncol; 2012 Apr; 23(4):981-9. PubMed ID: 21778301
[TBL] [Abstract][Full Text] [Related]
10. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
[TBL] [Abstract][Full Text] [Related]
11. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
12. Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma.
Chung CJ; Bao BY; Lin YC; Huang YL; Shiue HS; Ao PL; Pu YS; Huang CY; Hsueh YM
Sci Rep; 2020 Apr; 10(1):6640. PubMed ID: 32313131
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
14. Association between ACYP2 polymorphisms and the risk of renal cell cancer.
Wang Y; Zhang Y; Sun Y; Wu J; Chang J; Xiong Z; Niu F; Gu S; Jin T
Mol Genet Genomic Med; 2019 Nov; 7(11):e966. PubMed ID: 31487124
[TBL] [Abstract][Full Text] [Related]
15. Concomitance of Polymorphisms in Glutathione Transferase Omega Genes Is Associated with Risk of Clear Cell Renal Cell Carcinoma.
Radic TM; Coric VM; Pljesa-Ercegovac MS; Basta-Jovanovic GM; Radojevic-Skodric SM; Dragicevic DP; Matic MG; Bogdanovic LM; Dzamic ZM; Simic TP; Savic-Radojevic AR
Tohoku J Exp Med; 2018 Sep; 246(1):35-44. PubMed ID: 30224590
[TBL] [Abstract][Full Text] [Related]
16. Genetic variation in the GSTM3 promoter confer risk and prognosis of renal cell carcinoma by reducing gene expression.
Tan X; Wang Y; Han Y; Chang W; Su T; Hou J; Xu D; Yu Y; Ma W; Thompson TC; Cao G
Br J Cancer; 2013 Dec; 109(12):3105-15. PubMed ID: 24157827
[TBL] [Abstract][Full Text] [Related]
17. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
18. Risk of renal cell carcinoma and polymorphism in phase I xenobiotic metabolizing CYP1A1 and CYP2D6 enzymes.
Ahmad ST; Arjumand W; Seth A; Nafees S; Rashid S; Ali N; Hamiza OO; Sultana S
Urol Oncol; 2013 Oct; 31(7):1350-7. PubMed ID: 22281432
[TBL] [Abstract][Full Text] [Related]
19. Association of 3' nearby gene BTLA polymorphisms with the risk of renal cell carcinoma in the Polish population.
Partyka A; Tupikowski K; Kolodziej A; Zdrojowy R; Halon A; Malkiewicz B; Dembowski J; Frydecka I; Karabon L
Urol Oncol; 2016 Sep; 34(9):419.e13-9. PubMed ID: 27234378
[TBL] [Abstract][Full Text] [Related]
20. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
